Topic Area and Motivation: Chronic disease care management in diabetes type II patients, living at home and supported by telemonitoring equipment has proven to be both working and useful while adding health value from a clinical perspective. Managerial decisions need however to be based on quantified cost estimations. The challenge today is to show, in which patient groups, positive cost-benefit results can be obtained by the use of telemedicine equipment.
The problem statement: While numerous studies have shown clinical value and economical benefit separately, there is a need to identify the cost-benefit ratios applicable to different diabetic patient groups, with varying risk levels. The investment costs in expensive telemonitoring equipment need to be compared to associated clinical benefits obtained in the medium and long-term timeframe.
The interest, relevance and importance of the study lays in the cost estimating of care interventions provided to diabetes patient following ‘care pathways’ in home care settings While similar work has been undertaken in the acute care settings with start-end pathways, the cost estimation of the diabetes follow-up is challenged by a recurring loop-back care pathway.
Aims and hypothesis: While it is assumed that the use of telemedicine equipment and related care intervention costs are compensated by a reduction in complications and related health care costs, the aim of the study is to provide a simple model for cost-benefit analysis.
Methods: Workload evaluation methods are used to cost-estimate and cost-quantify identified care pathway variables. The resulting cost information is then used as input data in a simple microsimulation model. Microsimulation is designed to identify the target group of instable diabetic patients for whom the use of telemedicine supported monitoring would produce both clinical added value and be cost-effectiveness as compared to the conventional care delivery model.
Results: The microsimulation model is producing a breakeven point (cost benefit levels reached over determined periods of time) thus identifying parameters about which patient profiles can be cost-beneficially used for the telemedicine modality.
Table of Contents
CHAPTER 1: Traditional care delivery models and chronic disease management
1.1. Chronic diseases and the challenge to health systems
1.2. The specific case of Diabetes Disease
1.3. Limitations in the care delivery model
1.4. Bottlenecks in the care pathway
1.5. The need for rethinking
1.6. New expectations and requirements
1.7. A new variable in the equation: enabling technology
1.8. The research issue: Clinical value and economical benefits
1.9. Motivation for the research study
1.10. Aims, objectives and outline of the research study
CHAPTER 2: Literature Review
2.1. Focus of the literature review
2.2. The framework for chronic care management in diabetes condition
2.3. The conventional care delivery and care pathway
2.5. Failing to deliver clinical and economical outcomes
2.6. Variables associated to the limitations
2.7. The search for solutions
2.8. The potential of enabling telemedicine equipment
2.9. Telemedicine and Telemonitoring in Diabetes Care
2.9.1. Impacts on the clinical side
2.9.2. Impacts on the economical side
2.10. Bringing together clinical and economical effects
2.11. Extrapolation for the research perspective
3. CHAPTER 3: Methods
3.1. The Research Perspective
3.2. Reasons to choose the case study approach
3.3. System analysis
3.4. The telemedicine equipment and inbuilt functionalities
3.5. Cost-estimation of identified variables in the care pathways
3.6. Cost benefit and microsimulation modeling
4. CHAPTER 4: Results
4.1. The elements of the care delivery model
4.2. Care pathway and conventional care delivery model
4.3. Assessing the telemedicine equipment
4.4. The results produced by the case study
4.5. Telemedicine in the conventional care delivery model
4.6. Costing data on the conventional and telemedicine care pathways
4.7. Extrapolation of costs and transfer on a simulation model
4.8. The findings
5. CHAPTER 5: Conclusions, lessons Learnt, Recommandations
5.1. Summary and conclusions of the research undertaken
5.2. Research work for the future
5.3. Recommendations
Research Objectives and Core Themes
The primary aim of this dissertation is to evaluate whether the management of unstable type II diabetes patients can be optimized through telemedicine. By comparing conventional and telemonitoring-driven care pathways, the study seeks to determine the breakeven point for cost-benefit relationships and identify which patient profiles benefit most from technology-supported care.
- Analysis of care delivery models for chronic diabetes management.
- Evaluation of the clinical and economical impact of telemonitoring equipment.
- Utilization of workload assessment methods to quantify care pathway variables.
- Application of a microsimulation model to identify cost-effective patient cohorts.
- Reengineering of care processes to transition from reactive to proactive service models.
Excerpt from the book
1.2. The specific case of Diabetes Disease
According to Robert Beaglehole (WHO 2004) “diabetes is a growing and massive silent epidemic that has the potential to cripple health services in all parts of the world.” The quality of life reducing as well as cost-driving nature of Diabetes Mellitus disease (Appendix A: What is Diabetes disease type 2) has been shown by many studies and statistics. (WHO 2002, The Oxford Centre for Diabetes, The DCCT Research Group 1993, CDC 2004 and WrongDiagnosis.com) The Centre for disease control and prevention (2004) has evaluated the yearly average health care costs generated by a diabetic patient at 12500 USD as compared to the 2500 USD for the average US health care patient. These figures show that the complex illness of diabetes is, on the one hand, affecting an overall high number of people and is for that matter a public health issue of extent, while also being related to a high cost service patterns, based on evolving patient needs as complications emerge and progress and multiply. (CDC 2004, Kinsella 2003). For Wagner (2004) Diabetes is ‘the single greatest challenge facing organised medical practice.’ More generally also ‘more and more pressure has been exerted by third party payers to demonstrate the effectiveness of home care services through improvement in patient outcomes’. (Kinsella 2003: page xiii)
Summary of Chapters
CHAPTER 1: Traditional care delivery models and chronic disease management: This chapter establishes the challenge of chronic diseases, specifically diabetes, and highlights the limitations of current reactive care models.
CHAPTER 2: Literature Review: Provides an overview of existing research on telemedicine and ICTs in diabetes care, focusing on clinical and economical outcomes and the need for process reengineering.
CHAPTER 3: Methods: Describes the methodology, focusing on the use of an in-depth case study and system analysis to gather input data for a microsimulation model.
CHAPTER 4: Results: Presents the findings from the case study, including the dissection of the care delivery model and the cost-comparison between conventional and telemedicine pathways.
CHAPTER 5: Conclusions, lessons Learnt, Recommandations: Summarizes the research results, acknowledges study limitations, and provides recommendations for future research in chronic disease management.
Keywords
Telemedicine, Diabetes Mellitus, Telemonitoring, Chronic Disease Management, Care Pathway, Cost-Benefit Analysis, Microsimulation, Healthcare Technology, Primary Care, Proactive Care, Clinical Outcomes, Cost Estimation, Resource Allocation, Patient Profiling, eHealth
Frequently Asked Questions
What is the fundamental focus of this research?
The research focuses on evaluating the effectiveness of telemonitoring in the management of type II diabetes, specifically examining how it influences care pathways and long-term cost-benefit relationships.
What are the primary thematic fields covered?
The study spans health informatics, chronic disease management, healthcare economics, and the reengineering of clinical care delivery processes.
What is the core research objective?
The objective is to identify if and how telemedicine can transition diabetes care from a reactive, curative model to a proactive, preventative one while ensuring economic viability.
Which scientific methods are utilized?
The study employs a case study approach for data collection, system analysis to map workflows, and a microsimulation model to evaluate cost-effectiveness.
What is discussed in the main body of the work?
The main body examines current care limitations, the implementation of telemonitoring equipment, workload assessment metrics, and a comparative analysis of conventional versus telemedicine-enabled care paths.
Which keywords define the study?
The study is characterized by terms such as Telemedicine, Diabetes Care, Microsimulation, Cost-Benefit Analysis, and Care Pathway Reengineering.
How is the "breakeven point" defined in this study?
The breakeven point is the specific time frame in the patient's care duration where the initial, higher costs of telemedicine equipment are offset by the savings gained from reduced interventions and avoided hospitalizations.
Does the research generalize its findings?
No, the study emphasizes that its findings are based on a specific case scenario and are not meant to be generalized, but rather serve as a basis for further, more generic research models.
- Quote paper
- Marco ZEIMET (Author), 2004, Telemonitoring in Diabetes Care Management, Munich, GRIN Verlag, https://www.grin.com/document/42675
